NASS 2018 Annual Meeting
Tweet
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Buzz
Speakers
Matthew
Smuck, MD
Matthew Smuck, MD
Board of Directors: Spine Intervention Society (None); Consulting: Consultant & expert witness - State Farm (F), Spine Biopharma (Future Compensation Expected); Grants: Relievant Medsystems (F, Paid directly to institution/employer), ReWalk (E, Paid directly to institution/employer); Private Investments: Vivametrica (15.00%); Scientific Advisory Board: BlueJay Mobile-Health (Stock options), NuSpine (Stock options); Stock Ownership: BlueJay Mobile-Health (<1%), NuSpine (<1%); Trips/Travel: Spine Intervention Society, Board of Directors (B, Travel Expenses).
Sessions :
Symposium: Enhanced Recovery After Spine Surgery (ERASS) A-Z and How to Implement in Your Hospital
Section on Spinal Cord Injury: Controversies in Management
Home
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Tweet
Login
|
Back to top
ChirpE